Ivermectin and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported as a side effect among people who take Ivermectin (ivermectin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dolutegravir, and have Staphylococcal infection.

The phase IV clinical study analyzes which people have Acarodermatitis when taking Ivermectin. It is created by eHealthMe based on reports of 2,120 people who have side effects when taking Ivermectin from the FDA, and is updated regularly.

What is Ivermectin?

Ivermectin has active ingredients of ivermectin. eHealthMe is studying from 2,196 Ivermectin users. Check the latest studies of Ivermectin.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 238 drugs and 309 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

On Feb, 22, 2026

2,120 people reported to have side effects when taking Ivermectin.
Among them, 18 people (0.85%) have Acarodermatitis.

Among these 18 people:

How long have people been on Ivermectin when they have Acarodermatitis? *

What is the gender of people who have Acarodermatitis when taking Ivermectin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Acarodermatitis when taking Ivermectin? *

What are other drugs people take besides Ivermectin? *

What are other side effects people have besides Acarodermatitis? *

Drug Level Decreased: 5 people, 27.78%
Hypersensitivity: 4 people, 22.22%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 4 people, 22.22%
Pathogen Resistance: 3 people, 16.67%
Drug Resistance (reduction in effectiveness of a drug): 3 people, 16.67%
Rash Erythematous (redness of the skin): 2 people, 11.11%
Weakness: 2 people, 11.11%
Itching: 2 people, 11.11%
Drug Hypersensitivity: 1 person, 5.56%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 1 person, 5.56%

What are the existing conditions these people have? *

Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 27.78%
Hiv Infection: 4 people, 22.22%
Hepatic Enzyme Increased: 4 people, 22.22%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 4 people, 22.22%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 16.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 11.11%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 5.56%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 1 person, 5.56%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.56%
Stress And Anxiety: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ivermectin and have Acarodermatitis?

- Check whether Acarodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ivermectin:

Ivermectin (2,196 reports)

Acarodermatitis treatments and more:

Acarodermatitis (2,497 reports)

Browse all side effects of Ivermectin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acarodermatitis:

Acarodermatitis (238 drugs)

Browse all the conditions that are associated with Acarodermatitis:

Acarodermatitis (309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ivermectin (the active ingredients of Ivermectin) and Ivermectin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.